Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study
- Lena Lundorff
- , Per Sjøgren
- , Ole Bo Hansen
- , Torsten Jonsson
- , Per Rotbøll Nielsen
- , Lona Christrup
11
Citationer
(Scopus)